Lean protocol01 / 08

Investigational · information only

Lean · Investigational peptide

Retatrutide

Not available for enrollment

An evidence overview of investigational retatrutide. This is an informational catalog entry; retatrutide is not offered for enrollment here.

Individual review Simple plan choices

This treatment is not available to order

What’s included?

This page includes educational information and links to regulatory and research sources. It does not include a consultation for retatrutide, medication, supplies or a subscription.

The site does not collect payment or route this protocol to an enrollment funnel. Other Basis protocols have their own assessment and eligibility requirements.

How does enrollment work?

Start the secure intake in a new tab, then choose your final plan within the care service. Comparing durations here does not lock your choice or authorize payment. The care service handles assessment, prescribing decisions and payment terms.

Important information

Retatrutide is investigational and is not FDA-approved. The FDA says it cannot be used in compounding. This page is for information only.

THE PROTOCOL, EXPLAINED · Investigational peptide

Retatrutide.
Weight-management care.

Weight managementAppetite pathwaysIndividual care

Lean is an educational introduction to retatrutide, an investigational medicine being studied in metabolic research. It is not offered for enrollment or purchase through this page.

Research can be promising without establishing an approved treatment. If you are exploring weight-management care today, discuss currently available, appropriate options with a licensed clinician.

Explore the science and suitability below. Goals are not guarantees of treatment benefit.

START WITH YOUR HEALTH

Start with you.
Your goals. Your health.

This page does not assess anyone for retatrutide treatment. Trial eligibility is determined by the investigators and the study protocol.

For help with weight or metabolic health outside a trial, seek an assessment of established care options. Do not delay needed care while waiting for an investigational product.

THE THINKING BEHIND IT

Understand the science.
Make an informed choice.

Retatrutide is being studied for activity at GIP, GLP-1 and glucagon receptors. This three-receptor approach differs from semaglutide and tirzepatide, but a mechanism alone does not establish suitability or superiority.

Investigational results describe selected participants under study conditions. They are not a basis for self-treatment or for assuming that an online vial is the material used in a clinical trial.

Investigational

Clinical research is different from routine prescribing.

Three-receptor research

Studied at GIP, GLP-1 and glucagon receptors.

Information only

No subscription, payment, intake or shipment on this page.

THE EVERYDAY PICTURE

A clearer picture
of your care.

There is no Basis treatment timeline, dispensing schedule or plan commitment for retatrutide. The information here is intended to help you understand the distinction between research and available care.

Clinical-trial participation, where available, has its own eligibility, consent and oversight. It is not the same as buying a product marketed as a research peptide.

PERSONAL FROM THE START

What comes
with your plan.

This page includes educational information and links to regulatory and research sources. It does not include a consultation for retatrutide, medication, supplies or a subscription.

The site does not collect payment or route this protocol to an enrollment funnel. Other Basis protocols have their own assessment and eligibility requirements.

Delivery, storage & your supply

No retatrutide is dispensed or delivered through this page. The product imagery is conceptual, not a representation of available medication.

A vial offered online as a research product should not be assumed to have the identity, quality or supervision of a clinical-trial medicine.

MAKE AN INFORMED CHOICE

Know what
to consider.

Retatrutide is not FDA-approved. FDA states that it cannot be used in compounding under federal law and has not been found safe and effective for any condition.

Do not purchase or self-administer a product presented as retatrutide for human use on the basis of research publicity. Ask a qualified clinician about appropriate, available alternatives.

Sources & further reading

FDA: retatrutide and unapproved GLP-1 medicines Retatrutide phase 2 trial Retatrutide clinical research

Retatrutide · FAQs

A few things
you might be wondering.

Can I enroll in Lean here?

No. This is an information page and there is no retatrutide enrollment or purchase option.

Is retatrutide FDA-approved?

No. It remains investigational.

Can a pharmacy compound it?

FDA states that retatrutide cannot be used in compounding under federal law.

Are research vials the same as trial medication?

You should not assume that. A clinical trial has controlled sourcing, a study protocol and clinical oversight.

How do I find a legitimate trial?

Use ClinicalTrials.gov and discuss trial participation with a clinician. Eligibility and access are controlled by the research team.

What can I explore instead?

You can review other weight-management information on this site and discuss established treatment options with a licensed clinician.

Retatrutide

Retatrutide

Compare your plans

Retatrutide.
Weight-management care.

Start with you.
Your goals. Your health.